Mass drug administration for lymphatic filariasis elimination in a coastal state of India: A study on barriers to coverage and compliance

Infectious Diseases of Poverty

Volumn 3, Issue 1, 2014, Pages

  Hussain, Mohammad A ^a   Sitha, Ashok K ^b   Swain, Subhashisa ^c   Kadam, Shridhar ^c   Pati, Sanghamitra ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Government of Odisha   (India)

^c PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

Compliance; Consumption; Elimination; Lymphatic filariasis; Mass drug administration

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE ELIMINATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INDIA; LYMPHATIC FILARIASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MEDICATION COMPLIANCE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUESTIONNAIRE;

EID: 84988856977     PISSN: None     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/2049-9957-3-31     Document Type: Article

References (27)

1. Dreyer G, Coelho G: Lymphatic Filariasis: a potentially eradicable disease. Cadernos de Saúde Pública 1997, 13:537-543
2. Lymphatic filariasis: progress of disability prevention activities. Weekly epidemiological record, World Health Organization | 19 November 2004. 79:417-424 [http://www.who.int/wer/2004/en/wer7947.pdf]
3. Neglected Tropical Diseases, Hidden Successes, Emerging Opportunities. France: World Health Organization, Dept. of Control of Neglected Tropical Diseases, Geneva; 2009 [http://www.who.int/iris/handle/10665/44214#sthash. w9257Gz8.dpuf]
4. Progress Report 2000-2009 and Strategic Plan 2010-2020 of the Global Program to Eliminate Lymphatic Filariasis: Halfway Towards Eliminating Lymphatic Filariasis. France: World Health Organization, Geneva; 2011 [http://whqlibdoc.who.int/publications/2010/9789241500722_eng.pdf]
5. National Health policy. In Ministry of Health and Family Welfare, Government of India; 2002 [http://planningcommission.nic.in/sectors/health.php? sectors=hea]
6. Guidelines on Filariasis Control in India and its Elimination. National Vector Borne Disease Control Program; Ministry of Health and Family Welfare; Government of India; 2009 [http://nvbdcp.gov.in/doc/guidelines-filariasiselimination-india.pdf]
7. Ramaiah KD: Lymphatic filariasis elimination programme in India: progress and challenges. Trends Parasitol 2009, 25:7-8
8. Ottesen EA, Duke BOL, Karam M: Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75:491-503
9. Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JDF: Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis 2003, 188:1371-1381
10. Ramaiah KD, Das PK, Appavoo NC, Ramu K, Augustin DJ, Kumar KN, Chandrakala AV: A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Heal Tm Ih 2000, 5:842-847
11. Journal of Community Medicine_ January 2009_ Vol.doc. [http://www. docstoc.com/docs/122469684/Journal-of-Community-Medicine_-January-2009_-Voldoc]
12. Lahariya C, Mishra A: Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. J Vector Borne Dis 2008, 45:313-320
13. Esterre P, Plichart C, Sechan Y, Nguyen NL: The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health 2001, 6:190-195
14. Babu BV, Satyanarayana K: Factors responsible for coverage and compliance in mass drug administration during the Programme to Eliminate Lymphatic Filariasis in the East Godavari District, South India. Trop Doct 2003, 33:79-82
15. Babu BV, Kar SK: Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Heal Tm Ih 2004, 9:702-709
16. Directorate General of Health Services: Trend of Average Microfilaria Rates (%) in the State Since 2004. National Vector Borne DIsease Control Program; [http://www.nvbdcp.gov.in/fil-rate.html]
17. Cantey PT, Rout J, Rao G, Williamson J, Fox LM: Increasing compliance with mass drug administration programs for lymphatic filariasis in India through Education and Lymphedema Management Programs. PLoS Negl Trop Dis 2010, 4:e728
18. Babu BV, Mishra S: Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Trans R Soc Trop Med Hyg 2008, 102:1207-1213
19. Rath K, Nayak AN, Babu BV: Community's knowledge and perceptions about filarial elephantiasis and hydrocele in coastal Orissa, India. Asia-Pac J Public Heal Asia-Pac Acad Consort Public Heal 2007, 19:28-33
20. Showkath Ali MK, Rajendran R, Regu K, Mohanan MK, Dhariwal AC, Lal S: Study on the factors affecting the MDA programme in Kerala state. J Commun Dis 2007, 39:51-56
21. Krentel A, Fischer PU, Weil GJ: A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis 2013, 7:e2447
22. CDC-Epi InfoTM. [http://wwwn.cdc.gov/epiinfo/]
23. Bennett S, Woods T, Liyanage WM, Smith DL: A simplified general method for cluster-sample surveys of health in developing countries. World Heal Stat Q Rapp Trimest Stat Sanit Mond 1991, 44:98-106
24. McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, Lammie PJ, Lammie J, Rheingans R, Lafontant J: Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. Am J Trop Med Hyg 2003, 68:568-573
25. Norman RA, Chan MS, Srividya A, Pani SP, Ramaiah KD, Vanamail P, Michael E, Das PK, Bundy DA: EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect 2000, 124:529-541
26. Plaisier AP, Stolk WA, van Oortmarssen GJ, Habbema JD: Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol Today Pers Ed 2000, 16:298-302
27. Kumar A, Kumar P, Nagaraj K, Nayak D, Ashok L, Ashok K: A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India. J Vector Borne Dis 2009, 46:237-240